JAIPUR: When research reports from three different sectors — healthcare, consumer tech, and home appliances — in the Indian stock market tell a similar story — strong capacity expansion, improving margin outlook, and reliable balance sheets — it becomes interesting for investors to understand what common thread analysts see. Recent reports from ICICI Direct and Axis Direct have reaffirmed their confidence in Artemis Medicare, Lenskart Solutions, and LG Electronics India respectively. All three stocks maintain "Buy" ratings, but each has its own distinct growth story.
Artemis Medicare: Healthcare Network Expanding from Gurugram to Raipur
This hospital chain, started by the promoters of Apollo Tyres Group, is rapidly transitioning from a single-asset model to a multi-asset platform. ICICI Direct has given the stock a "Buy" rating with a target of ₹410 at the current price of ₹345, implying potential upside of about 19%. The company's Q1FY27 performance was impressive — consolidated revenue grew 12.7% to ₹287.3 crore, while EBITDA surged about 36% and margins improved by 341 basis points to 19.6%.
The real story is capacity expansion. Tower-4 being built on the Gurugram campus will add over 200 beds in the next 18-22 months, focusing specifically on advanced pediatric and gynecology care. Additionally, the 300-bed hospital in Raipur has been operational since July, though management estimates it will take 15-18 months to reach breakeven. The company also has a 650-bed VIMHANS hospital project in South Delhi, expected to start in FY29. Shareholders have also approved a ₹700 crore QIP, which will be used for new brownfield acquisitions. Analysts believe that as the company moves away from single-hospital risk, its valuation multiple could approach multi-asset players like Apollo Hospitals or Narayana Health.
Lenskart Solutions: AI-Driven Eyewear Model Taking Margins to New Heights
ICICI Direct has made Lenskart a "Conviction Pick," setting a target of ₹850 at the current price of ₹693 — implying about 23% upside. This report marks coverage initiation and highlights Lenskart's rapidly growing dominance in India's unorganized eyewear market.
India's eyewear market is expected to grow at 13% CAGR between FY25-30 to reach ₹1.48 lakh crore, with organized players' market share expected to increase from 22% to 31%. Lenskart's biggest strength is its vertically integrated manufacturing model — the company's material cost is 35-40% lower than industry average, allowing it to sell products to customers at 50-70% cheaper prices compared to local opticians. In FY26, the company's consolidated EBITDA margin reached 19.9%, up from just 7% in FY23.
The road ahead is equally interesting. The company is building a new manufacturing facility in Hyderabad that will add 50 million units of additional capacity. In international markets, a dual-brand strategy (Owndays and Lenskart) is working in Singapore, Japan, and the Middle East, while its House of Brands portfolio — including brands like John Jacobs, Vincent Chase, Meller — is driving premiumization. Analysts expect revenue, EBITDA, and PAT to grow at 27%, 37%, and 59% CAGR respectively during FY26-29E.
LG Electronics India: Margin Pressure Temporary, Recovery Expected
Axis Direct has maintained a "Buy" rating on LG Electronics India in its annual analysis report, setting a target of ₹1,965 at the current price of ₹1,646, indicating about 19% upside. Listed via an ₹11,605 crore IPO in October 2025, the company went through a challenging period in FY26. Revenue grew only 1% to ₹24,605 crore, while EBITDA margin fell 23 percentage points to 9.8% due to raw material inflation and currency volatility. Consequently, net profit also declined 24%.
But analysts view this decline as temporary. The company's balance sheet is debt-free, has a cash balance exceeding ₹4,476 crore, and ROCE remains strong at 28.9%. The company maintains market leadership in categories like refrigerators (28.8%), washing machines (31.5%), and OLED TVs (60%+). A third manufacturing plant being built at Sri City in Andhra Pradesh (₹5,000 crore investment) will start operations from Q3FY27, with component localization expected to increase from the current 55.2% to 70% over the next 3-4 years. Under its "Make-in-India, Make-for-India, Make-India-Global" strategy, the company exports to over 50 countries and has launched ranges like "Essential Series" for tier-2/3 markets.
What Matters for Investors
A common theme runs through all three reports — focus on capacity and competitive moat despite short-term pressure. Artemis is betting on new beds and multi-asset model, Lenskart on AI and vertical integration, and LG on localization and scale. Of course, risks exist too — Artemis's Raipur hospital ramp-up could be slow, Lenskart's medical technology alternatives like LASIK surgery could reduce demand, and LG could face continued currency volatility and commodity inflation pressure. As every brokerage report states, markets are subject to risks, and it's essential to do your own research before investing.
Source: This article is based on research reports issued by ICICI Securities (ICICI Direct) on Artemis Medicare and Lenskart Solutions (both September 10, 2026), and Axis Securities (Axis Direct)'s "Axis Annual Analysis 2026" report on LG Electronics India (September 10, 2026).
